AMA CPT® Assistant - 2001 Issue 12 (December)
Pathology and Laboratory/Microbiology (December 2001)
December 2001 page 6a Coding Consultation Microbiology, Pathology and Laboratory, 87400 (Q&A) Question How should a rapid in vitro assay for the direct and qualitative detection of influenza A and B viral antigens be reported? AMA Comment The appropriate method of reporting a rapid in vitro assay for the direct and qualitative detection of influenza A and B viral antigens is with code 87400 , Infectious agent antigen detection by enzyme immunoassay technique, qualitative or semiquantitative, multiple step method; Influenza, A or B, each. If testing was performed separately for influenza A and B, then code 87400 should be...
Subscribe or sign in to view the full article.
Article Overview
This article reviews a microbiology coding question from CPT® Assistant about how to report rapid in vitro testing for influenza A and B antigen detection. It is relevant to coders, billers, laboratory staff, and compliance teams who work with pathology and laboratory services and need to understand the article’s coding discussion and CPT context.
Why This Topic Matters
Laboratory and microbiology coding often depends on correctly identifying the reported service and the applicable CPT code set context. This article helps readers understand the scope of the coding consultation and the type of guidance offered for influenza antigen testing.
What You Will Learn
- The laboratory and microbiology coding topic addressed in the consultation
- How the article frames a CPT coding question and AMA commentary
- The general reporting context for rapid influenza antigen testing in a laboratory setting
- Whether the discussion addresses single or separate testing scenarios
Who Should Read This
- Medical coders
- Pathology and laboratory billing staff
- Microbiology laboratory personnel
- Compliance professionals
- Revenue cycle teams
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com